18:31 IST
NSE
Merger & Restructuring
Cohance Lifesciences Merger & Restructuring Worth ₹95 Cr
Cohance Lifesciences invested USD 10 million (₹95 Crore) into its subsidiary NJ Bio, Inc. to subscribe for new Compulsorily Convertible Preferred Stock.
- Value
- ₹95.00 Cr